{
  "success": true,
  "sourceFile": "C:\\Users\\panik\\Documents\\GitHub\\Protcol2USDMv3\\input\\trial\\NCT03057977_DAPA_HF\\NCT03057977_DAPA_HF_SAP.pdf",
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39
  ],
  "modelUsed": "gemini-3-flash-preview",
  "sapData": {
    "analysisPopulations": [
      {
        "id": "pop_1",
        "name": "Screened set",
        "text": "The Screened set (SCR) includes all subjects who signed an informed consent form.",
        "populationType": "Other",
        "instanceType": "AnalysisPopulation",
        "label": "SCR",
        "populationDescription": "The Screened set (SCR) includes all subjects who signed an informed consent form.",
        "criteria": "Signed informed consent form"
      },
      {
        "id": "pop_2",
        "name": "Randomized set",
        "text": "The Randomized set (RS) includes all subjects who were randomized to a treatment group in the trial.",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "RS",
        "populationDescription": "The Randomized set (RS) includes all subjects who were randomized to a treatment group in the trial.",
        "criteria": "Randomized to a treatment group"
      },
      {
        "id": "pop_3",
        "name": "Treated set",
        "text": "The Treated set (TS) includes all subjects who were randomized and received at least one dose of study drug.",
        "populationType": "Safety",
        "instanceType": "AnalysisPopulation",
        "label": "TS",
        "populationDescription": "The Treated set (TS) includes all subjects who were randomized and received at least one dose of study drug.",
        "criteria": "Randomized AND received >=1 dose of study drug"
      },
      {
        "id": "pop_4",
        "name": "Intention-to-treat set",
        "text": "The efficacy analyses will follow the intention-to-treat (ITT) principle in assigning patients to treatment groups, i.e. patients will be analysed as randomised. In this trial, the ITT approach is defined as the analysis of all randomized patients.",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "ITT",
        "populationDescription": "The efficacy analyses will follow the intention-to-treat (ITT) principle in assigning patients to treatment groups, i.e. patients will be analysed as randomised. In this trial, the ITT approach is defined as the analysis of all randomized patients.",
        "criteria": "All randomized patients"
      },
      {
        "id": "pop_5",
        "name": "Treated set – Follow-up",
        "text": "The Treated set – Follow-up (TS-FU) includes all subjects in the Treated set who have completed the follow-up visit.",
        "populationType": "Safety",
        "instanceType": "AnalysisPopulation",
        "label": "TS-FU",
        "populationDescription": "The Treated set – Follow-up (TS-FU) includes all subjects in the Treated set who have completed the follow-up visit.",
        "criteria": "In Treated set AND completed follow-up visit"
      }
    ],
    "characteristics": [
      {
        "id": "char_1",
        "name": "LVEF",
        "code": "LVEF",
        "codeSystem": "http://www.cdisc.org/baseline-characteristics",
        "codeSystemVersion": "2024-03-29",
        "decode": "LVEF",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Left ventricular ejection fraction categorized as ≤30%, >30% to ≤35%, or >35%"
      },
      {
        "id": "char_2",
        "name": "eGFR (CKD-EPI)cr",
        "code": "EGFR_(CKD-EPI)CR",
        "codeSystem": "http://www.cdisc.org/baseline-characteristics",
        "codeSystemVersion": "2024-03-29",
        "decode": "eGFR (CKD-EPI)cr",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Estimated glomerular filtration rate at baseline"
      },
      {
        "id": "char_3",
        "name": "Diabetes mellitus status",
        "code": "DIABETES_MELLITUS_ST",
        "codeSystem": "http://www.cdisc.org/baseline-characteristics",
        "codeSystemVersion": "2024-03-29",
        "decode": "Diabetes mellitus status",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Status of diabetes mellitus (DM) at baseline"
      },
      {
        "id": "char_4",
        "name": "NTproBNP",
        "code": "NTPROBNP",
        "codeSystem": "http://www.cdisc.org/baseline-characteristics",
        "codeSystemVersion": "2024-03-29",
        "decode": "NTproBNP",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "N-terminal pro B-type natriuretic peptide levels used for inclusion thresholds"
      }
    ],
    "summary": {
      "populationCount": 5,
      "characteristicCount": 4
    }
  }
}